• Follow
  • Follow
  • Home
  • About
  • Technology
  • Pipeline
  • News
  • Investors
  • Publications
  • Contact
  • Follow
  • Follow
  • Home
  • About
  • Technology
  • Pipeline
  • News
  • Investors
  • Publications
  • Contact
Post 5

Post 5

by Web Developer | Oct 14, 2020 | Test

Post 5

Post 4

by Web Developer | Oct 14, 2020 | Test

Post 5

Post 3

by Web Developer | Oct 14, 2020 | Test

Post 5

Post 2

by Web Developer | Oct 14, 2020 | Test

Post 5

Post 1

by Web Developer | Oct 14, 2020 | Test

Recent Posts

  • ALS – Can ‘Mitometin’ finally be a successful treatment for this rare disease?
  • Choosing a Career in Science?
  • BII awards 14 million EUR to startups and research projects
  • ALS start-up funded by BII
  • Ground-breaking ALS start-up accepted into the Creation House program of BioInnovation Institute (BII), securing funding of EUR 1.3 million

Recent Comments

    2npharma
    Last week, to coincide with the International Day Last week, to coincide with the International Day of Women and Girls in Science, Anne Skøttrup Mørkholt, 2N Pharma's Project Manager talked about her career to date in bio-pharmacology, what she enjoys about her role in the search for cures to incurable diseases and advice for girls looking to make it their career too. Read the article at https://lnkd.in/e6kqJAk #WomenInScience #ALS #womeninstem #science #stem #research #scicomm #scientist #phdlife #phd #womenempowerment #steminist #phdstudent #womeninmedicine #sciencecommunication #womenintech #stemgirls #womendoingscience #biology #pharma
    At today's 31st International Symposium on #ALS #M At today's 31st International Symposium on #ALS #MND, look out for Anne Skøttrup Mørkholt who's presenting our novel drug candidate #Mitometin. She will introduce our approach to targeting #mitochondrial dysfunction as a treatment for #ALS #alsmndsymp
    Follow on Instagram

    LinkedIn
    Twitter

    About
    Technology
    Pipeline
    News
    Investors
    Publications
    Contact

    Policies, Terms & Conditions
    Website Terms and Conditions
    Data Privacy Policy
    Cookie Policy
    GDPR Compliance
    2N Pharma ApS
    Novi Science Park, Niels Jernes Vej 10, 9220 Aalborg Ø, Denmark
    BioInnovation Institute, Ole Maaløes Vej 3, 2200 København N, Denmark
    CVR: 41169303 VAT: DK41169303 D-U-N-S: 306192737
    email: info@2npharma.com

    2N PharmaFollow

    2N Pharma
    2NPharma2N Pharma@2NPharma·
    28 Feb

    Today it's #rarediseaseday2021 and #2NPharma is sharing our hypothesis that the key to treating #ALS and other similar neuro-degenerative diseases is in tackling the metabolic energy balance in affected mitochondria. #mnd https://tinyurl.com/y9p5pb37

    Reply on Twitter 1366029315612299264Retweet on Twitter 1366029315612299264Like on Twitter 1366029315612299264Twitter 1366029315612299264
    Load More...